Cytotoxic Effector Mechanisms in AIDS

  • S. Cunningham-Rundles
  • C. E. Metroka
  • B. Safai
  • M. Krim
  • B. Y. Rubin
  • G. Hayward
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 187)


The development of the Acquired Immunodeficiency Disease Syndrome, AIDS, in the United States has occurred primarily in certain groups, i.e. homosexual and bisexual men (1,2), I.V. drug abusers (3,4), Haitians (5), and hemophiliacs receiving Factor VIII concentrates (6). Evidence for AIDS in blood transfusion recipients and children of drug abusing or Haitian parents associated with apparent transmission of a newly described retrovirus, HTLV-III, LAV (7,8) has provoked study of critical conditions for AIDS development. It seems logical to assume that AIDS develops in a series of stages, the earliest of which may not be accompanied by any obvious clinical symptoms. Deficiencies in cell mediated immunity have been clearly documented by ourselves and others in patients with AIDS-related opportunistic infections (9,10) and AIDS-related Kaposi’s sarcoma. In addition, we and others have focused much attention upon homosexual men with generalized lymphadenopathy (11–14). Although these patients do not fit the criteria for CDC defined AIDS at the present time, we have observed that an increasingly large number of our originally described population have gone on to develop CDC defined AIDS (11).


Effector Cell Natural Killer Activity Generalize Lymphadenopathy Peripheral Blood Mononuclear Epstein Barr Virus Genome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M.S. Gottlieb, R. Schroff, H.M. Schanker, J.D. Weisman, P.T. Fan, R.A. Wolf, and A. Saxon, Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency, N. Engl. J. Med. 305: 1425–1431 (1981).PubMedCrossRefGoogle Scholar
  2. 2.
    H. Masur, M.A. Michelis, J.B. Greene, I. Onorato, R.A. Vande Sfouve, R.S. Holzman, G. Wormser, L. Brettman, M. Lange, and S. Cunningham- Rundles, A community acquired outbreak of Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction, N. Engl. J. Med. 305: 1431–1438 (1981).PubMedCrossRefGoogle Scholar
  3. 3.
    F.P. Siegal, C. Lopez, G.S. Hammer, A.E. Brown, S.J. Kornfeld, J. Gold, J. Hassett, S.Z. Hirschman, C. Cunningham-Rundles, B.R. Adelsbert, D.M. Parham, M. Siegal, S. Cunningham-Rundles, and D. Armstrong, Severe acquired immunodeficiency in male homosexuals manifested by chronic perianal ulcerative herpes simplex lesions, N. Engl. Jg. Med. 305: 1439–1444 (1981).CrossRefGoogle Scholar
  4. 4.
    H. Masur, M.A. Michelis, G.P. Wormser, S. Lewin, J. Gold, M.A. Tapper, J. Giron, C.W. Lerner, D. Armstrong, U. Setia, J.A. Sender, R.S. Siebken, P.Nicholas, F.P. Siegal, and S. Cunningham-Rundles, Previously healthy women with opportunistic infection vs. the initial manifestation of a community acquired cellular immunodeficiency extension of an emerging syndrome, Arm. Int. Med. 97: 533–539 (1983).Google Scholar
  5. 5.
    J. Vieira, E. Frank, R.J. Spira, and S.H.Landesman, Acquired immune deficiency in Haitians: opportunistic infections in previously healthy Haitians, N. Engl. J. Med. 308: 125–129 (1983).PubMedCrossRefGoogle Scholar
  6. 6.
    J.H. Elliott, W.L.Hoppes, M.S. Platt, J.G. Thomas, I.P. Patel, and A. Gansar, The acquired immunodeficiency syndrome and Mycobacterium- avium intracellular bacteremia in a patient with hemophilia, Ann. Int. Med. 98: 290–293 (1983).PubMedGoogle Scholar
  7. 7.
    J.L. Curran, P.N. Lawrence, H. Jaffe, J.E. Kaplan, L.D. Zyle, M. Chamber- land, R. Weinstein, K.J. Lui, L.B. Schönberger, T.J. Spira, W.J. Alexander, G. Swinger, A. Amman, S. Solomon, D. Auerbach, D. Mildvan, R. Stoneburner, J.M. Jason, H.W. Haverkos, and B.L. Evatt, Acquired immunodeficiency syndrome (AIDS) associated with transfusions, N. Engl. J. Med. 310: 69–75 (1984).PubMedCrossRefGoogle Scholar
  8. 8.
    H.W. Jaffe, D.P. Frances, M.F. McLane, C. Cabradilla, J.W. Carran, B.W. Kilbourne, D.M. Lawrence, H.W. Haverkos, T.J. Spira, R.Y. Dodd, J. Gold, D. Armstrong, A. Ley, J. Groopman, J. Mullins, T.L. Lee, and M. Essex, Transfusion-associated AIDS: serologic evidence of human T- cell leukemia virus infection of donors, Science 223: 1309–1311 (1984).PubMedCrossRefGoogle Scholar
  9. 9.
    R.E. Stahl, A. Friedman-Kien, R. Dubin, M. Marmor, and S. Zolla-Pazner, Immunologie abnormalities in homosexual men. Relationship to Kaposi’s sarcoma, Am. J. Med. 73: 171–178 (1982).PubMedCrossRefGoogle Scholar
  10. 10.
    S. Cunningham-Rundles, Analysis of cellular immune deficiency in acquired immunodeficiency syndrome, in: “The Acquired Immune Deficiency Syndrome and Infections of Homosexual Men,” P. Ma and D. Armstrong, Yorke, New York (1983).Google Scholar
  11. 11.
    C.E. Metroka, S. Cunningham-Rundles, M.S. Pollack, J.A. Sonnabend, J.M. Davis, B. Gordon, R.D. Fernandes, and J. Mouradian, Generalized lymph- adenopathy in homosexual men, Ann. Int. Med. 99: 585–591 (1982).Google Scholar
  12. 12.
    J.L. Ziegler, J.A. Beckslead, P.A. Volberding, D.I. Abrams, A.M. Levine, R.J. Lukes, P.S. Gill, R.L. Burkes, P.R. Meyer, C.E. Metroka, J. Mouradian, A. Moore, S.A. Riggs, J.J. Butler, F.C. Cabanillas, E. Hersh, G.R. Newell, L.J. Laubanstein, D. Knowles, C. Odajnyk, B. Raphael, B. Koziner, C. Urmacher, and B.D. Clarkson, Non-Hodgkins lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the Acquired Immunodeficiency Syndrome, N. Engl. J. Med. 311: 565–570 (1984).PubMedCrossRefGoogle Scholar
  13. 13.
    A.M. Levine, P.B. Meyer, M.K. Begandy, J.W. Parker, C.R. Taylor, L. Irwin, and R.J. Lukes, Development of B cell lymphomas in homosexual men, Ann. Int. Med. 100: 7–13 (1984).PubMedGoogle Scholar
  14. 14.
    Persistant, generalized lymphadenopathy among homosexual males, MMWR 31: 249–251 (1982).Google Scholar
  15. 15.
    A. Ono, D.B. Amos, and H.S. Koren, Selective cellular natural killing against human leukaemic T cells and thymus, Nature 266: 546–547 (1977).PubMedCrossRefGoogle Scholar
  16. 16.
    S. Cunningham-Rundles, J.A. Hansen, and B. Dupont, Lymphocyte transformation to mitogens and antigens, in: “Clinical Immunobiology,” Vol. 3, F. Bach and R.A. Good, Academic Press, New York (1976).Google Scholar
  17. 17.
    S. Cunningham-Rundles, D. Filippa, P. Antonelli, D. Braun, and H. Ashi- kari, Natural killer cell activity of peripheral blood and regional lymph node lymphocytes in breast cancer, J_. Nat. Can. Inst. 67: 585–590 (1981).Google Scholar
  18. 18.
    S. Cunningham-Rundles, R.S. Bockman, and B.Y. Rubin, Modulation of natural cell-mediated cytotoxicity of T colonies and PBL by Interleukin–2, in: “Natural Cell-Mediated Immunity,” pp. 415–420, R.B. Herberman, ed., Academic Press, New York (1982).Google Scholar
  19. 19.
    S.D. Hayward, L. Nogee, and G.S. Hayward, Organization of repeated regions within the Epstein-Barr virus DNA molecule, J. Virol. 33: 507–521 (1980).Google Scholar
  20. 20.
    S. Cunningham-Rundles, B. Safai, C. Metroka, S.E. Krown, B.Y. Rubin, and W.E. Stahl, Lymphocyte effector function in vitro in the Acquired Immune Deficiency Syndrome, in: “AIDS: The Epidemic of Kaposi’s Sarcoma and Opportunistic Infections,” pp. 153–159, A.E. Friedman-Kien and L.J. Lauberstein, eds., Masson, USA (1984).Google Scholar
  21. 21.
    J.Y. Djeu, N. Stocks, K. Zoon, G.J. Stanton, T. Timonen, and R.B. Herberman, Positive selfrecognition of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses, J. Ex£. Med. 156: 1222–1234 (1982).CrossRefGoogle Scholar
  22. 22.
    C. Lopez, P.A. Fitzgerald, and F.P. Siegal, Severe Acquired Immune Deficiency Syndrome in male homosexuals: Diminished capacity to make interferon a in vitro associated with severe opportunistic infections, J. Infect. Pis. 148: 962–966 (1983).CrossRefGoogle Scholar
  23. 23.
    H.W. Murray, B.Y. Rubin, H. Masur, and R.B. Roberts, Impaired production of lymphokines and immune (gamma) interferon in the Acquired Immunodeficiency Syndrome, N. Engl. J. Med. 31: 883–889 (1984).CrossRefGoogle Scholar
  24. 24.
    S. Levin, T. Hahn, Z.T. Handzel, V. Bregman, N. Barzila, R. Myer, M. Tinowitz, E. Galili-Waisstub, and Z. Bentwich, Activated interferon system in healthy homosexuals, J. Clin. Immunol, (in press), (1984).Google Scholar
  25. 25.
    R.J. Melder and M. Ho, Modulation of natural killer cell activity in mice after interferon induction: depression of activity and depression of in vitro enhancement by interferon, Infect. Immun. 36: 990–995 (1982).Google Scholar
  26. 26.
    S.H. Golub, F. Dorey, D. Hara, D.L. Morton, and M.W. Burk, Systemic administration of human leukocyte interferon to melanoma patients, J. Nat. Can. Inst. 68: 703–710 (1982).Google Scholar
  27. 27.
    M. DeWaele, C. Thielemans, and B.K.G. Van Camp, Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies, N. Engl. J. Med. 304: 460–462 (1981).CrossRefGoogle Scholar
  28. 28.
    A.B. Rickinson, D.J. Moss, L. E. Wallace, M. Rowe, I.S. Misko, M.A. Epstein, and J.H. Pope, Long term T cell mediated immunity to Epstein- Barr virus, Can. Res. 41: 4216–4221 (1981).Google Scholar
  29. 29.
    J. Seeley, E. Svedmyr, O. Weiland, G. Klein, E. Moller, E. Eriksson, K. Andersson, and L. Van der Waal, Epstein-Barr virus selective T cells in infectious mononucleosis are not restricted to HLA and B antigens, J. Immunol. 127: 293–300 (1981).PubMedGoogle Scholar
  30. 30.
    Y. Tanaka, K. Sugamura, Y. Hinuma, H. Sato, and K. Okochi, Memory of Epstein-Barr virus specific cytotoxic T cells in normal seropositive adults as revealed by an in vitro restimulation method, J Immunol. 125: 1426–1431 (1980).PubMedGoogle Scholar
  31. 31.
    R. Palacios, Epstein-Barr virus increases the proliferative response and the generation of suppressor and cytotoxic T-cell functions in autologous mixed lymphocyte reaction, Scand. J. Immunol. 15: 17–24 (1982).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • S. Cunningham-Rundles
    • 1
  • C. E. Metroka
    • 1
  • B. Safai
    • 1
  • M. Krim
    • 1
  • B. Y. Rubin
    • 1
  • G. Hayward
    • 1
  1. 1.Memorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations